Filter
423
Filtered Results: 423
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
59
New Publications
132
Language
Document type
No document type
222
Guidelines
79
Studies & Reports
53
Strategic & Response Plan
26
Manuals
22
Fact sheets
8
Training Material
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Videos
1
Countries / Regions
Kenya
26
South Africa
16
India
16
Ghana
15
Nigeria
15
Western and Central Europe
14
Uganda
14
Eastern Europe
11
Ethiopia
11
Nepal
10
Rwanda
10
Namibia
10
Global
9
Sierra Leone
8
Malawi
8
Tanzania
8
Zambia
8
Latin America and the Carribbean
6
South–East Asia Region
6
Senegal
5
Philippines
5
Cambodia
5
Bangladesh
5
Botswana
5
Liberia
5
Africa
4
West and Central Africa
4
East and Southern Africa
4
Russia
4
Lesotho
3
Zimbabwe
3
Mozambique
3
Middle East and North Africa
3
Haiti
2
Asia
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
Lebanon
2
Brazil
2
Sudan
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Ukraine
1
Benin
1
Gambia
1
Cameroon
1
Syria
1
Laos
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Jordan
1
Western Pacific Region
1
Paraguay
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
55
Public Health
16
Women & Child Health
8
Pharmacy & Technologies
8
Capacity Building
6
Key Resources
6
Toolboxes
TB
51
Pharmacy
47
AMR
41
COVID-19
29
HIV
22
NTDs
20
Planetary Health
4
NCDs
4
Rapid Response
3
Caregiver
3
Refugee
2
Specific Hazards
1
Cholera
1
Ebola & Marburg
1
Malaria
1
Zika
1
Polio
1
Global Health Education
1
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Meeting Report
Bangkok, Thailand 8-11 August 2016
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
Rwanda Guidelines for variation to registered pharmaceutical products.
The Department of Health (DOH) has developed a National Integrated Sexual and Reproductive Health and Rights (SRHR) Policy.1 This policy addresses the many cross-cutting issues relating to SRH service provision, drawing together the principles, rights, and guidance for planning and implementation th...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
WHO Guidelines for the Treatment of Human African Trypanosomiasis. Web Annex B
